About the Company
Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $RANI News
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call Transcript March 20, 2024 Rani Therapeutics Holdings, Inc. beats earnings expectations. Reported EPS is ...
RANI: 2023 Results
RANI READ THE FULL RANI RESEARCH REPORT Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) began 2024 with topline results from ...
Buy Rating for Rani Therapeutics: Promising Clinical Data and Significant Market Potential
H.C. Wainwright analyst Mitchell Kapoor has maintained their bullish stance on RANI stock, giving a Buy rating on March 21. Mitchell Kapoor ...
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Announced ...
Rani Therapeutics Holdings, Inc. Class A
View Rani Therapeutics Holdings, Inc. Class A RANI stock quote prices, financial information, real-time forecasts, and company news from CNN.
RANI Stock Earnings: Rani Therapeutics Hldgs Beats EPS for Q4 2023
RANI stock results show that Rani Therapeutics Hldgs beat analyst estimates for earnings per share the fourth quarter of 2023 ...
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
Rani Therapeutics will host a conference call and live webcast at 4:30 p.m. ET / 1:30 p.m. PT on March 20, 2024. Individuals interested in listening to the live conference call may do so by using the ...
Earnings Outlook For Rani Therapeutics Hldgs
Rani Therapeutics Hldgs RANI is set to give its latest quarterly earnings report on Wednesday, 2024-03-20. Here's what ...
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Spectral AI (MDAI) and Pyxis Oncology (PYXS)
Harrison covers the Healthcare sector, focusing on stocks such as MoonLake Immunotherapeutics, Rani Therapeutics Holdings, and Apogee Therapeutics, Inc. The word on The Street in general, suggests a ...
Recap: Rani Therapeutics Hldgs Q4 Earnings
Rani Therapeutics Hldgs RANI reported its Q4 earnings results on Wednesday, March 20, 2024 at 04:05 PM. Here's what investors need to know about the announcement. Earnings. Rani T ...
Relmada Therapeutics FY 2023 Earnings Preview
Relmada Therapeutics is set to release their fiscal year earnings results on March 18th after the market closes.
Target looks to double bonuses this year, Bloomberg News says
"Based on Target's performance in 2023, including the $2 billion in additional profit growth our team delivered that exceeded ...
Loading the latest forecasts...